To enable the early diagnosis of AKI, researchers have investigated various novel biomarkers, such as neutrophil gelatinase-associated lipocalin (NGAL) [12] and kidney injury molecule-1 (KIM-1) [13]. This evidence concerns the gene HAVCR1 and acute kidney injury.